A critical breakthrough in cancer investigation is arising with the use of mini-antibodies to reactivate mutated p53. This vital malignant protector protein is frequently inactivated in various forms of cancer, causing https://networkbookmarks.com/story21963619/vhh-fragments-restore-tumor-suppressor-p53-new-new-pathway-for-cancer-therapy